Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Lear
LEA
$8.56B
| $434K | 0.01% |
+3,166
| New | +$392K |
|
852
Coca-Cola Femsa
KOF
$23.6B
| $427K | 0.01% |
7,049
-5,171
| -42% | -$304K |
|
853
Intuitive Surgical
ISRG
$134B
| $423K | 0.01% |
+2,145
| New | +$402K |
|
854
Guardant Health
GH
$22.9B
| $422K | 0.01% |
+5,400
| New | +$389K |
|
|
SRC
855
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $422K | 0.01% |
8,586
+710
| +9% | +$35.3K |
|
856
Columbus McKinnon
CMCO
$509M
| $421K | 0.01% |
10,507
-4,965
| -32% | -$192K |
|
857
Inogen
INGN
$149M
| $418K | 0.01% |
6,124
+896
| +17% | +$56.2K |
|
858
Methode Electronics
MEI
$507M
| $418K | 0.01% |
+10,623
| New | +$386K |
|
859
American Water Works
AWK
$26.9B
| $417K | 0.01% |
3,392
-22,300
| -87% | -$2.7M |
|
|
IMGN
860
DELISTED
Immunogen Inc
IMGN
| $415K | 0.01% |
+81,364
| New | +$276K |
|
861
Dominion Energy
D
$58.6B
| $414K | 0.01% |
5,003
-150
| -3% | -$12.3K |
|
862
State Street
STT
$51.4B
| $411K | 0.01% |
5,190
-11,423
| -69% | -$804K |
|
863
AGNC Investment
AGNC
$12.9B
| $410K | 0.01% |
+23,204
| New | +$395K |
|
864
AES
AES
$10.5B
| $406K | 0.01% |
20,403
-1,492
| -7% | -$26.7K |
|
865
Ethan Allen Interiors
ETD
$595M
| $406K | 0.01% |
21,327
-4,216
| -17% | -$78.5K |
|
|
CIR
866
DELISTED
CIRCOR International, Inc
CIR
| $405K | 0.01% |
8,750
+702
| +9% | +$29K |
|
|
CVSA
867
Covista Inc
CVSA
$4.51B
| $404K | 0.01% |
11,543
-1,737
| -13% | -$59.8K |
|
|
SC
868
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $404K | 0.01% |
17,301
+2,097
| +14% | +$50.9K |
|
869
Live Nation Entertainment
LYV
$42.4B
| $402K | 0.01% |
+5,626
| New | +$381K |
|
870
Service Corp International
SCI
$11.4B
| $402K | 0.01% |
8,735
-5,670
| -39% | -$256K |
|
871
Adient
ADNT
$1.54B
| $400K | 0.01% |
+18,808
| New | +$417K |
|
872
Raymond James Financial
RJF
$33.7B
| $399K | 0.01% |
+6,689
| New | +$386K |
|
873
GSK
GSK
$105B
| $395K | 0.01% |
6,729
| – | – |
|
874
News Corp Class A
NWSA
$16.4B
| $395K | 0.01% |
27,900
-64,586
| -70% | -$869K |
|
|
SFIX
875
Stitch Fix
SFIX
$446M
| $394K | 0.01% |
15,336
-30,842
| -67% | -$716K |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.